AVEO PHARMACEUTICALS
Updated 4 days ago
One Marina Park Drive 12th Floor Boston, MA 02210
AVEO is an oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for cancer patients...
On January 19, 2023, AVEO Oncology was acquired by LG Chem, Ltd. ("LG Chem"), expanding LG Chem's Life Sciences' oncology portfolio. AVEO now operates as an LG Chem company, leveraging the companies' combined capabilities to deliver continued progress across clinical and pre-clinical stage anti-cancer therapies and accelerating the commercialization of new anti-cancer drugs developed by LG Chem...
AVEO's strategy is to grow into a global oncology leader through the development and commercialization of its current pipeline programs and the acquisition of additional innovative programs.
Also known as: AVEO, Aveo Oncology, AVEO Pharmaceuticals, Inc.
Associated domains: aveobiotherapeutics.net, aveooncology.org, aveotherapeutics.com, thehumanresponse.net